Argenx
ARGX
#571
Rank
S$48.77 B
Marketcap
$815.69
Share price
1.54%
Change (1 day)
22.97%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$5.63

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$5.60. In 2022 the company made an earnings per share (EPS) of -$17.66.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.63-68.13%
2022-$17.66